Hsp90 and Cdc37 - A chaperone cancer conspiracy

Current Opinion in Genetics and Development

Volumn 15, Issue 1, 2005, Pages 55-61

  Pearl, Laurence H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN 37; CELL PROTEIN; CHAPERONE; HEAT SHOCK PROTEIN 90; PROTEIN KINASE; REGULATOR PROTEIN;

BIOCHEMISTRY; CANCER CHEMOTHERAPY; CANCER GENETICS; CELL TRANSFORMATION; GENE OVEREXPRESSION; GENE TARGETING; ONCOGENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW;

ANIMALS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CHAPERONINS; DIMERIZATION; HSP90 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS;

EID: 12344291243     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2004.12.011     Document Type: Review

References (52)

1. P. Workman Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone Cancer Lett 206 2004 149 157
2. R. Bagatell, and L. Whitesell Altered Hsp90 function in cancer: a unique therapeutic opportunity Mol Cancer Ther 3 2004 1021 1030
3. U. Banerji, I. Judson, and P. Workman The clinical applications of heat shock protein inhibitors in cancer - present and future Curr Cancer Drug Targets 3 2003 385 390
4. C. Prodromou, and L.H. Pearl Structure and functional relationships of Hsp90 Curr Cancer Drug Targets 3 2003 301 323
5. v-src with the cellular proteins pp50 and pp90 Curr Top Microbiol Immunol 123 1986 1 22
6. L.F. Stancato, Y.-H. Chow, K.A. Hutchinson, G.H. Perdew, R. Jove, and W.B. Pratt Raf exists in a native heterocomplex with Hsp90 and p50 that can be reconstituted in a cell-free system J Biol Chem 268 1993 21711 21716
7. K. Dai, R. Kobayashi, and D. Beach Physical interaction of mammalian CDC37 with CDK4 J Biol Chem 271 1996 22030 22034
8. S.J. Lavictoire, D.A. Parolin, A.C. Klimowicz, J.F. Kelly, and I.A. Lorimer Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII J Biol Chem 278 2003 5292 5299 The authors describe the first direct observation of Hsp90-Cdc37 binding to a receptor tyrosine kinase.
9. •] provide the first evidence for dependence of LKB1 on Hsp90-Cdc37. Given that LKB1 is a tumour suppressor, unlike almost all other Hsp90-Cdc37-dependent protein kinases, this observation raises concerns that protracted exposure to Hsp90 inhibitors might promote tumourigenesis.
10. •].
11. H. Tatebe, and K. Shiozaki Identification of Cdc37 as a novel regulator of the stress-responsive mitogen-activated protein kinase Mol Cell Biol 23 2003 5132 5142
12. cdc37 is required for mixed-lineage kinase (MLK) 3 signaling J Biol Chem 279 2004 19457 19463
13. M. Mikolajczyk, and M.A. Nelson Regulation of stability of cyclin-dependent kinase CDK11p p110 and a caspase-processed form, CDK11 p46, by HSP90 Biochem J 384 2004 361 367
14. T. Bouwmeester, A. Bauch, H. Ruffner, P.O. Angrand, G. Bergamini, K. Croughton, C. Cruciat, D. Eberhard, J. Gagneur, and S. Ghidelli A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway Nat Cell Biol 6 2004 97 105
15. P. Lee, J. Rao, A. Fliss, E. Yang, S. Garrett, and A.J. Caplan The Cdc37 protein kinase-binding domain is sufficient for protein kinase activity and cell viability J Cell Biol 159 2002 1051 1059
16. S.R. Schwarze, V.X. Fu, and D.F. Jarrard Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival Cancer Res 63 2003 4614 4619 This study uses a dominant negative mutant to show that blocking Cdc37 function blocks proliferation and trips cells into apoptosis.
17. J. Shao, A. Irwin, S.D. Hartson, and R.L. Matts Functional dissection of cdc37: characterization of domain structure and amino acid residues critical for protein kinase binding Biochemistry 42 2003 12577 12588
18. S. Bandhakavi, R.O. McCann, D.E. Hanna, and C.V. Glover A positive feedback loop between protein kinase CKII and Cdc37 promotes the activity of multiple protein kinases J Biol Chem 278 2003 2829 2836
19. S. Bandhakavi, R.O. McCann, D.E. Hanna, and C.V. Glover Genetic interactions among ZDS1,2, CDC37, and protein kinase CK2 in Saccharomyces cerevisiae FEBS Lett 554 2003 295 300
20. •] demonstrate that CK2-dependent phosphorylation of Serine 13 in the extreme N-terminus of Cdc37 has a significant role in the assembly of Hsp90-Cdc37-kinase complexes.
21. •].
22. cdc37 Cell 116 2004 87 98 The first structural insight into Cdc37, this study delineates the binding site of Cdc37 on Hsp90, and shows how Cdc37 arrests the Hsp90 ATPase cycle.
23. C. Prodromou, S.M. Roe, R. O'Brien, J.E. Ladbury, P.W. Piper, and L.H. Pearl Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone Cell 90 1997 65 75
24. C.E. Stebbins, A.A. Russo, C. Schneider, N. Rosen, F.U. Hartl, and N.P. Pavletich Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent Cell 89 1997 239 250
25. S.M. Roe, C. Prodromou, R. O'Brien, J.E. Ladbury, P.W. Piper, and L.H. Pearl The structural basis for inhibition of the Hsp90 molecular chaperone, by the anti-tumour antibiotics radicicol and geldanamycin J Med Chem 42 1999 260 266
26. J.K. Owens-Grillo, M.J. Czar, K.A. Hutchison, K. Hoffmann, G.H. Perdew, and W.B. Pratt A model of protein targeting mediated by immunophilins and other proteins that bind to hsp90 via tetratricopeptide repeat domains J Biol Chem 271 1996 13468 13475
27. cdc37 binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site J Biol Chem 273 1998 20090 20095
28. C. Prodromou, G. Siligardi, R. O'Brien, D.N. Woolfson, L. Regan, B. Panaretou, J.E. Ladbury, P.W. Piper, and L.H. Pearl Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones EMBO J 18 1999 754 762
29. cdc37 J Biol Chem 277 2002 20151 20159
30. K. Richter, P. Muschler, O. Hainzl, J. Reinstein, and J. Buchner Sti1 is a non-competitive inhibitor of the Hsp90 ATPase J Biol Chem 278 2003 10328 10333
31. C. Prodromou, B. Panaretou, S. Chohan, G. Siligardi, R. O'Brien, J.E. Ladbury, S.M. Roe, P.W. Piper, and L.H. Pearl The ATPase cycle of Hsp90 drives a molecular 'clamp' via transient dimerization of the N-terminal domains EMBO J 19 2000 4383 4392
32. B.T. Scroggins, T. Prince, J. Shao, S. Uma, W. Huang, Y. Guo, B.G. Yun, K. Hedman, R.L. Matts, and S.D. Hartson High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients Biochemistry 42 2003 12550 12561
33. •] identify regions in the N-termini of protein kinase clients that are required for interaction with the Hsp90-Cdc37 complex.
34. •].
35. P.D. Jeffrey, L. Tong, and N.P. Pavletich Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors Genes Dev 14 2000 3115 3125
36. A.D. Basso, D.B. Solit, G. Chiosis, B. Giri, P. Tsichlis, and N. Rosen Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function J Biol Chem 277 2002 39858 39866
37. S. Sato, N. Fujita, and T. Tsuruo Modulation of akt kinase activity by binding to hsp90 Proc Natl Acad Sci USA 97 2000 10832 10837
38. cdc37 is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules Biochemistry 39 2000 7631 7644
39. P. Lee, A. Shabbir, C. Cardozo, and A.J. Caplan Sti1 and Cdc37 can stabilize Hsp90 in chaperone complexes with a protein kinase Mol Biol Cell 15 2004 1785 1792
40. J. Shao, S.D. Hartson, and R.L. Matts Evidence that protein phosphatase 5 functions to negatively modulate the maturation of the Hsp90-dependent heme-regulated eIF2 alpha kinase Biochemistry 41 2002 6770 6779
41. G. Siligardi, B. Hu, B. Panaretou, P.W. Piper, L.H. Pearl, and C. Prodromou Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle J Biol Chem 2004 (Epub; ahead of print) This study shows that Cdc37 and Aha1 can co-exist in Hsp90 complexes, but Cdc37 and p23/Sba1 cannot.
42. B. Panaretou, G. Siligardi, P. Meyer, A. Maloney, J.K. Sullivan, S. Singh, S.H. Millson, P.A. Clarke, S. Naaby-Hansen, and R. Stein Activation of the ATPase activity of Hsp90 by the stress-regulated co-chaperone Aha1 Molec Cell 10 2002 1307 1318
43. A. Chadli, I. Bouhouche, W. Sullivan, B. Stensgard, N. McMahon, M.G. Catelli, and D.O. Toft Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90 Proc Natl Acad Sci USA 97 2000 12524 12529
44. M.R. Gerber, A. Farrell, R.J. Deshaies, I. Herskowitz, and D.O. Morgam Cdc37 is required for association of the protein kinase Cdc28 with G1 and mitotic cyclins Proc Natl Acad Sci USA 92 1995 4651 4655
45. P.K. Westwood, I.V. Martin, and P.A. Fantes Fission yeast Cdc37 is required for multiple cell cycle functions Mol Genet Genomics 271 2004 82 90
46. L. Stepanova, G. Yang, F. DeMayo, T.M. Wheeler, M. Finegold, T.C. Thompson, and J.W. Harper Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia Oncogene 19 2000 2186 2193
47. L. Stepanova, M. Finegold, F. DeMayo, E.V. Schmidt, and J.W. Harper The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues Mol Cell Biol 20 2000 4462 4473
48. I.B. Weinstein Cancer. Addiction to oncogenes - the Achilles heal of cancer Science 297 2002 63 64
49. S.L. Rutherford, and S. Lindquist Hsp90 as a capacitor for morphological evolution Nature 396 1998 336 342
50. A. Bergman, and M.L. Siegal Evolutionary capacitance as a general feature of complex gene networks Nature 424 2003 549 552 A fascinating theoretical study of the concept of evolutionary capacitance, for which the Hsp90 system is the best described example.
51. A. Kamal, L. Thao, J. Sensintaffar, L. Zhang, M.F. Boehm, L.C. Fritz, and F.J. Burrows A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors Nature 425 2003 407 410 The authors make the key observation that Hsp90 is far more engaged in multi-protein complexes in tumour cells than it is in normal cells. The composition of these complexes remains to be determined.
52. M. Vilenchik, D. Solit, A. Basso, H. Huezo, B. Lucas, H. He, N. Rosen, C. Spampinato, P. Modrich, and G. Chiosis Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90 Chem Biol 11 2004 787 797